期刊文献+

利伐沙班及依诺肝素预防腰椎术后下肢深静脉血栓的效果比较 被引量:11

Comparison of the effects of rivaroxaban and enoxaparin on preventing deep venous thrombosis after lumbar surgery
下载PDF
导出
摘要 目的观察比较利伐沙班与依诺肝素预防腰椎术后下肢深静脉血栓(DVT)的效果。方法选取我院100例择期腰椎手术的DVT高危患者,随机分为利伐沙班组(A组,50例)和依诺肝素组(B组,50例)。分别于术后6 h和12 h开始口服利伐沙班和注射依诺肝素;均于患者能下床活动后停药。分别于术前和术后7 d检测血D-二聚体,记录凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)。术后记录48 h引流量,术后7 d行双下肢血管超声检查。结果两组患者均无明显的下肢DVT形成和肺栓塞发生。A组术后48 h的引流量,术后7 d肌肉静脉血栓发生率及D-二聚体、PT、APTT的水平较B组差异均无统计学意义(P>0.05),且均无切口周围血肿、消化道出血、硬膜外血肿等不良反应发生。结论利伐沙班预防腰椎术后下肢DVT形成的效果与依诺肝素相当,且安全有效。 Objective To observe the effects of rivaroxaban and enoxaparin on preventing deep venous thrombosis( DVT) after lumbar surgery. Methods 100 high-risk cases with DVT undergoing elective lumbar spine surgery in our hospital were selected and randomly divided into rivaroxaban group( group A,n = 50) and enoxaparin group( group B,n = 50). Patients in both groups were orally administrated with rivaroxaban and enoxaparin at 6 hours and 12 hours perceptively until all the patients could walk off bed. The levels of D-dimer,PT and APTT in blood were detected 7days before and after the operation perceptively. Drainages volumes of 48 hours after the operation were recorded.Double lower extremity vascular ultrasound was performed 7 days after the operation. Results No significant formations of lower extremity DVT and pulmonary embolism were noted. There was no significant difference in drainages at48 hours,incidence of muscular veniplex thrombosis at 7 days after the operation,and the levels of D-dimer,PT and APTT between group A and group B( P〉0. 05). No adverse events,such as hematoma around the incision,gastrointestinal bleeding,epidural hematoma were observed. Conclusion Rivaroxaban and enoxaparin have the same effects on preventing DVT after lumbar surgery and they are found to be safe and effective.
出处 《实用药物与临床》 CAS 2015年第1期39-42,共4页 Practical Pharmacy and Clinical Remedies
关键词 利伐沙班 依诺肝素 深静脉血栓 腰椎 Rivaroxaban Enoxaparin Deep vein thrombosis Lumbar
  • 相关文献

参考文献15

  • 1Wu O, Clark P, Lowe GD, et al. Thrombophilia and venous thromboembolism after total hip or knee replacement surgery : a systematic review [ J ]. J Thromb Haemost, 2013,3 ( 4 ) : 811 - 813.
  • 2Mills RM, Berkowitz RD, Damaraju CV, et al. Initiation of ri- varoxaban following low molecular weight heparin for throm- boprophylaxis after tital joint replacement: the safe, simple transitions study [ J]. Thromb Res ,2012,130 ( 5 ) :709-715.
  • 3Gerlach R, Raabe A, Beck J, et al. Postoperative nadroparin ad- ministration for prophylaxis of thromboembolic events is not associated with an increased risk of hemorrhage after apinal surgery[J]. Eur Spine J,2010,13 ( 1 ) :9-13.
  • 4李旭,邢壮杰,赵晖,郝国强,李润生,郑新,魏立春.介入溶栓治疗下肢深静脉血栓形成疗效分析[J].中国医药,2013,8(5):633-634. 被引量:11
  • 5Chens JS, Arnold SL, Schulman VS, et al. Anticoagulation risk in spine surgery [ J]. Spine ,2012,35 ( 9 ) : 117-124.
  • 6Kubitza D, Becka M, Zuehlsdorf M, et al. Body weight has limited influence on the safety, tolerability, pharmacokinetics, orpharmacodynamics of rivaroxaban in healthy subjects [ J ]. J Clin Pharmaco1,2013,47 ( 2 ) :218-226.
  • 7Kubitza D, Becka M, Mueck W, et al. Safety, tolerability, pharmacodynamics, and pharmaeokinetics of rivaroxaban ano- ral. direct factor Xa inhibitor are not affected by aspirin[ J]. J Clin Pharmacol,2012,46(9) :981-990.
  • 8Perka C. Preopertive versus postoperative initiation of throm- boprophylaxis following major orthopedie surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants [J]. Thromb J, 2013,9 ( 11 ) : 17-22.
  • 9Elias A, Cadene A, Elias M, et al. Extended lower limb venous ultrasound for the diagnosis of proximal and distal vein throm- bosis in asymptomatic patients after total hip replacement[ J]. Eur J Vasc Endovasc Surg, 2011,27 ( 5 ) :438-444.
  • 10Etikssona BI, Rosencherb N, Friedman RJ, et al. Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxapafin after total hip or knee arthm- plasty[J]. Thromb Res,2012,130 ( 2 ) :201-206.

二级参考文献27

  • 1蔡小玲,林伟峰,叶进元.深部血栓性静脉炎的溶血栓治疗[J].广州医药,1996,27(5):25-26. 被引量:4
  • 2吴孟超,吴在德.黄家驷外科学.7版,北京:人民卫生出版社,2008:1585.
  • 3陈灏珠,董强.实用内科学[M].12版.北京:人民卫生出版社,2005:2669-2670
  • 4张阳德,黄志强,DavidL.血管外科诊疗手册.北京:人民军医出版社,2005:164.
  • 5Yamaki T, Hamahata A, Soejima K, et al. Factors predicting de- velopment of post-thrombotic syndrome in patients with a t~rst epi- sode of deep vein thrombosis:preliminary report. Eur J Vasc Endo- vasc Surg, 2011,41 ( 1 ) : 126-133.
  • 6Titus JM, Moise MA, Bena J, et al. Iliofemoral stenting for venous occlusive disease. J Vasc Surg, 2011,53(3) :706-712.
  • 7Kelly J,Rudd A,Lewis R. Venous thromboembolism after acute stroke[J].{H}STROKE,2001,(1):262-267.
  • 8Kubitza D,Becka M,Mueck W. Safety,tolerability,pharmacodynamics,and pharmacokinetics of rivaroxaban-an oral,direct factor Xa inhibitor-are not affected by aspirin[J].{H}Journal of Clinical Pharmacology,2006,(9):981-990.
  • 9Eriksson B I,Borris L C,Friedman R J. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty[J].{H}New England Journal of Medicine,2008,(26):2765-2775.
  • 10Kakkra A K,Brenner B,Dahl O E. Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty:a doubleblind,randomized controlled trial[J].{H}LANCET,2008,(9632):31-39.

共引文献23

同被引文献93

  • 1January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society [ J ]. J Am Coil Cardiol, 2014,64 ( 21 ) : e 1-76.
  • 2Pilgrim T, Windecker S. Republished: Antiplatelet therapy for secondary prevention of coronary artery disease [J ]. Postgrad Med J, 2015,91 ( 1075 ) : 284-290.
  • 3Rubboli A, Faxon DP, Juhani Airaksinen KE, et al. The optimal management of patients on oral anticoagulation undergoing coronary artery stenting. The 10th Anniversary Overview [J]. Thromb Haemost, 2014,112(6) : 1080-1087.
  • 4Mennuni MG, Halperin JL, Bansilal S, et al. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Pereutaneous Coronary Intervention (from the AVIATOR Registry) [J]. Am J Cardiol, 2015,pii: S0002-9149(15) 01039-5.
  • 5Dewilde WJ, Janssen PW, Verheugt FW, et al. Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review [J]. J Am Coil Cardiol, 2014,64(12) : 1270-1280.
  • 6Fiedler KA, Maeng M, Mehilli J, et al. Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug- Eluting Stent Implantation: The ISAR-TRIPLE Trial [J]. J Am Coll Cardiol, 2015,65(16) : 1619-1629.
  • 7Kikkert WJ, van Geloven N, van der Laan MH, et al. The prognostic value of bleeding Academic research consortium ( BARC ) -defined bleeding complications in ST-segment elevation myocardial infarction: a comparison with the TIMI (Thrombolysis In Myocardial Infarction), GUSTO (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries), and ISTH (International Society on Thrombosis and Haemostasis)Bleeding classifications [J]. J Am Coll Cardiol, 2014,63(18) : 1866-1875.
  • 8Hansen ML, S rensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation [J]. Arch Intern Med, 2010,170(16) : 1433-1441.
  • 9Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial [J]. Lancet, 2013, 381(9872) : 1107-1115.
  • 10Goldman ME1, Pearee LA, Hart RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study) [J]. J Am Soc Echocardiogr, 1999,12(12) : 1080-1087.

引证文献11

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部